Foundayo Insurance Coverage · Verified April 13, 2026
Does Insurance Cover Foundayo? 2026 Coverage Paths, Copays, and What to Do If You’re Denied
Last reviewed:
Does insurance cover Foundayo? Sometimes — but the real answer depends entirely on which type of insurance you have and what your specific plan covers. Here’s what we verified:
If you have commercial insurance that covers Foundayo, eligible patients may pay as little as $25/month using the Foundayo Savings Card. If your commercial plan doesn’t cover weight-loss medications — and according to Mercer, 51% of large employers (500+ employees) still did not cover GLP-1 weight-loss drugs in 2025 — you’ll pay $149–$349/month self-pay depending on your dose, with Lilly’s Self-Pay Savings Card. Medicare Part D doesn’t cover Foundayo for weight loss under standard rules. Lilly has stated that eligible Medicare Part D beneficiaries may access Foundayo for approximately $50/month starting July 1, 2026 through the CMS Medicare GLP-1 Bridge, though CMS has not yet confirmed Foundayo’s inclusion. Medicaid coverage varies — only 13 state fee-for-service Medicaid programs covered GLP-1s for obesity as of January 2026, per KFF.
The honest version nobody leads with:
Foundayo is not a universal “$25 weight-loss pill.” That $25 figure only applies if your commercial insurance already covers the drug and you qualify for Lilly’s savings card — which itself is capped at $100 in savings per monthly fill and $1,000 per year. If your plan excludes weight-loss medications, self-pay pricing starts at $149/month for the lowest dose and climbs to $299–$349 at maintenance doses depending on refill timing. We think it’s better to know that now than to find out at the pharmacy counter.
Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
Does Insurance Cover Foundayo? The Verified Coverage Decision Grid
We assembled this from Eli Lilly’s published terms, CMS guidance, KFF Medicaid data, and Ro’s coverage tools — because no single page had it in one place. Sources are cited inline throughout the page.
| Your insurance | Covered? | What you’d pay | The catch | Fastest next step |
|---|---|---|---|---|
| Commercial — plan covers Foundayo | Yes, with hoops | As low as $25/mo with Foundayo Savings Card | Savings card caps at $100/mo (1-month fill) and $1,000/year. 10 fills/year max. Expires 12/31/2026. Government beneficiaries excluded. | Check your formulary or use Ro's free coverage checker |
| Commercial — plan does NOT cover Foundayo | Not as covered benefit; self-pay pricing available | $149 (0.8 mg) / $199 (2.5 mg) / $299 (5.5–17.2 mg) with Self-Pay Savings Card | Top doses (14.5 mg, 17.2 mg) increase to $349/mo if you don't refill within 45 days. Self-Pay Card is a separate program from the covered-commercial card. | Use the Self-Pay Savings Card through LillyDirect or retail pharmacy |
| Medicare Part D — before July 2026 | No — excluded by federal law for weight loss | $149–$349/mo self-pay (regular prices without savings card) | Foundayo commercial Savings Card excludes government beneficiaries. Self-Pay Savings Card has separate restrictions. | Self-pay through LillyDirect or retail pharmacy |
| Medicare Part D — July 1, 2026 onward | Potentially, via the Medicare GLP-1 Bridge | $50/mo if Bridge covers Foundayo | CMS confirmed Wegovy and Zepbound for the Bridge. Lilly states Foundayo will be included at $50/mo starting July 2026, but CMS has not yet confirmed this as of April 2026. | See Medicare section below — check eligibility with your prescriber |
| Medicaid | Depends on your state | Varies; may be $0 where covered | Only 13 state Medicaid fee-for-service programs covered GLP-1s for obesity as of January 2026 — down from 16 in late 2025. CMS BALANCE Model may expand this from May 2026 but does not guarantee coverage. | Check your state Medicaid preferred drug list directly |
| No insurance | N/A — self-pay only | $149–$349/mo (regular Lilly pricing) | Higher doses cost more. The 14.5 mg and 17.2 mg doses drop to $299 only through Lilly's Self-Pay Journey Program with 45-day refill requirement. | Compare self-pay channels and budget for dose escalation |
Sources: Lilly Foundayo Full Terms & Conditions (April 2026); CMS GLP-1 Bridge FAQ (March 2026); KFF Medicaid GLP-1 tracker (January 2026); LillyDirect pricing (April 2026).
Already see your situation above?
Ro’s GLP-1 Insurance Coverage Checker contacts your insurer directly and returns a personalized report — no prescription required, no commitment to treatment. Free for commercial insurance.
Check Your Foundayo Insurance Coverage — Free on Ro →Works for commercial insurance · Medicare/Medicaid: see sections below
If You Have Commercial Insurance: When Does Foundayo Actually Get Covered?
Commercial coverage is the path most people mean when they search “does insurance cover Foundayo” — and it’s the messiest to navigate. The short version: some plans cover it, many don’t, and the ones that do almost always add friction.
According to Mercer’s employer surveys, 49% of large employers (500+ employees) covered GLP-1 weight-loss medications in 2025, up from 44% in 2024. KFF found that 19% of firms with 200+ workers covered them in their largest plan. Coverage is growing — but the majority of employer plans still exclude weight-loss drugs. And some employers who previously covered them are now pulling back due to rising utilization costs.
This matters because your employer’s decision about the weight-loss drug category often matters more than whether Foundayo specifically is on a formulary. If your plan has a blanket exclusion for anti-obesity medications, Foundayo won’t be covered regardless of medical necessity.
The Two Foundayo Savings Cards: They’re Not the Same Program
This is the single most confusing thing about Foundayo pricing, and most pages get it wrong. Lilly runs two separate savings card programs with different eligibility rules:
Foundayo Savings Card
For covered-commercial patients
- ✓Reduces copay to as low as $25/month
- ✓Cap: $100/mo (1-month), $200 (2-month), $300 (3-month)
- ✓Annual cap: $1,000 · Max 10 fills/year
- ⚠Expires 12/31/2026
- ✗Government beneficiaries excluded
Foundayo Self-Pay Savings Card
For commercial patients plan doesn't cover
- ✓Caps cost at $149 (0.8 mg) / $199 (2.5 mg) / $299 (5.5–17.2 mg)
- ⚠14.5 mg & 17.2 mg stay at $299 only with 45-day refill
- ⚠Must have commercial insurance that does NOT cover Foundayo
- ✗Cannot seek reimbursement from third-party payers or HSA/FSA
If Foundayo Is on Your Formulary
Your provider will likely need to submit a prior authorization. Authorization requirements are common for GLP-1 weight-loss medications — Mercer found that nearly all large employers covering obesity drugs now apply some form of utilization management. Documentation typically includes:
- →Your BMI (typically 30+ or 27+ with a weight-related comorbidity)
- →Documented weight-related conditions (hypertension, type 2 diabetes, sleep apnea, cardiovascular disease)
- →Evidence of prior lifestyle modification attempts (some plans require this)
PA timelines vary from days to 2–3 weeks. Once approved, enroll in the Foundayo Savings Card at foundayo.lilly.com/coverage-savings.
If Your Plan Excludes Weight-Loss GLP-1s
Option 1 — Request a formulary exception
If your plan covers other GLP-1s (for diabetes) but excludes Foundayo specifically, your provider can argue medical necessity: needle aversion preventing injectable GLP-1 use, drug interactions with alternatives, or documented treatment failures.
Option 2 — Use self-pay pricing now
Lilly’s Self-Pay Savings Card caps your cost at $149–$299/month by dose. Fill through LillyDirect (home delivery), GoodRx at 70,000+ retail pharmacies, or Amazon Pharmacy.
Option 3 — Switch plans at open enrollment
Check whether alternative plans cover GLP-1s for weight management during your next enrollment window.
The fastest way to find out where you stand
Ro offers a free GLP-1 Insurance Coverage Checker that contacts your insurer directly — returning a report showing whether Foundayo is covered, whether prior authorization is required, and your estimated copay. Free, takes minutes, no prescription needed.
About Ro’s membership fee: Ro’s membership is separate from medication cost — $39 for the first month, then as low as $74/month with an annual plan. The membership is not covered by insurance. The coverage check itself is free, with no membership required.
Check Your Exact Foundayo Coverage — Free, No Prescription Required →Does Medicare Cover Foundayo?
Medicare Part D has historically excluded coverage for weight-loss drugs by federal law. As of April 2026, that statutory exclusion still applies to standard Part D coverage. But something new is happening — and the details matter more than the headline.
What Changes on July 1, 2026
CMS created a Medicare GLP-1 Bridge — a short-term demonstration running July 1 through December 31, 2026 — that gives eligible Medicare Part D beneficiaries access to GLP-1 medications at a $50/month copay.
A critical detail to be transparent about:
As of the CMS FAQ published March 2026, the Bridge names Wegovy and Zepbound as the covered medications. Foundayo wasn’t approved until April 1, 2026. Lilly’s press release states that eligible Medicare Part D beneficiaries “may be able to get Foundayo for $50 per month, beginning July 1, 2026” — but CMS has not yet published an updated FAQ confirming Foundayo’s inclusion. We expect CMS to update its Bridge drug list as the program approaches.
Who Qualifies for the Medicare GLP-1 Bridge
CMS published three eligibility tiers. You only need to meet one:
| Tier | BMI Requirement | Required Diagnosis |
|---|---|---|
| Tier 1 | BMI ≥ 35 at time of initiating GLP-1 therapy | None beyond BMI |
| Tier 2 | BMI ≥ 30 | Heart failure with preserved ejection fraction (HFpEF), OR uncontrolled hypertension (systolic >140 or diastolic >90 on 2+ antihypertensives), OR chronic kidney disease stage 3a or above |
| Tier 3 | BMI ≥ 27 | Prediabetes (per ADA guidelines), OR previous myocardial infarction, OR previous stroke, OR symptomatic peripheral artery disease |
Source: CMS Medicare GLP-1 Bridge FAQ, published March 2026. BMI is measured at time of initiating GLP-1 therapy, not at time of the PA request.
Note on common misreporting: Several competing pages compress these into “BMI 35+ or BMI 27+ with conditions,” completely omitting the distinct Tier 2 (BMI ≥ 30 with its own qualifying conditions). We verified these directly against the CMS FAQ.
How the Bridge Actually Works
The Bridge operates completely outside normal Part D. Your Part D plan doesn’t administer it, doesn’t bear the risk, and doesn’t need to opt in. CMS runs it through a single central processor. Your prescriber submits the prior authorization to CMS’s central processor — not to your Part D plan. If your doctor sends it to the plan, it won’t process correctly.
Eligible Plan Types
You must be enrolled in one of these for 2026: standalone PDP, MA-PD (Medicare Advantage with drug coverage), SNPs, EGWPs, or LI NET. Not eligible: PACE, private fee-for-service plans (unless also in a PDP), cost contracts, fallback plans, or religious fraternal benefit plans. Dually eligible beneficiaries (Medicare + Medicaid) may qualify if enrolled in an eligible Part D plan and meeting clinical criteria.
What About the Foundayo Savings Card on Medicare?
The commercial Foundayo Savings Card explicitly excludes government insurance beneficiaries. The Bridge itself also does not allow manufacturer copay cards or discount programs to be applied on Bridge claims. If you’re on Medicare, your pricing path is the Bridge ($50/month if Foundayo is confirmed) or regular self-pay pricing ($149–$349/month depending on dose).
What Happens After December 31, 2026
The Bridge ends. Continued coverage depends on the BALANCE Model launching for Part D plans in January 2027. To continue, you’d need to be enrolled in a Part D plan that chose to participate. CMS’s target date to notify plan sponsors was April 30, 2026 — meaning we’ll know soon whether BALANCE has enough participation to proceed. For a complete walkthrough, see our Medicare GLP-1 Bridge Program guide.
Does Medicaid Cover Foundayo?
As of January 2026, KFF identified only 13 state Medicaid fee-for-service programs covering GLP-1s for obesity treatment — down from 16 in October 2025. Four states — California, New Hampshire, Pennsylvania, and South Carolina — eliminated coverage due to budget pressures. Several more are considering restrictions.
What the BALANCE Model Means (and Doesn’t Mean)
CMS’s BALANCE Model allows state Medicaid agencies to begin coverage as early as May 2026. Three critical caveats:
- 1.Voluntary. States choose whether to participate, and many face severe budget constraints.
- 2.Manufacturers must participate too. Coverage depends on negotiations concluding successfully.
- 3.CMS explicitly states the model "does not guarantee coverage for any individual." Even in participating states, prior authorization and BMI criteria will apply.
How to Check Your State
Don’t rely on national summaries. Call your state Medicaid office or managed care plan and ask: “Is orforglipron (Foundayo) on the preferred drug list for weight management?” If not, ask whether your state is participating in the BALANCE Model. If your state doesn’t cover Foundayo, self-pay pricing starts at $149/month for the starting dose.
How Much Does Foundayo Cost With Insurance vs. Without?
| Dose | Commercial + Savings Card | Self-Pay Savings Card | Medicare Bridge | Regular price (no card) |
|---|---|---|---|---|
| 0.8 mg (starter) | As low as $25 | $149 | $50 | $149 |
| 2.5 mg (titration) | As low as $25 | $199 | $50 | $199 |
| 5.5 mg (maintenance) | As low as $25 | $299 | $50 | $299 |
| 9 mg (maintenance) | As low as $25 | $299 | $50 | $299 |
| 14.5 mg (maintenance) | As low as $25 | $299* | $50 | $349 |
| 17.2 mg (max) | As low as $25 | $299* | $50 | $349 |
*$299 for 14.5 mg and 17.2 mg requires refilling within 45 days through Lilly’s Self-Pay Journey Program; otherwise $349/mo. Sources: Lilly Foundayo Full Terms & Conditions (April 2026); CMS GLP-1 Bridge FAQ (March 2026).
Annualized Cost Reality
Best case (commercial + savings card)
~$300/year
Self-pay, starting dose (0.8 mg)
~$1,788/year
Self-pay at maintenance ($299/mo)
~$3,588/year
Medicare Bridge (6 months, July–Dec)
~$300 total
About HSA and FSA
If you use the covered-commercial Savings Card: The card terms state you may not seek reimbursement from health savings, flexible spending, or other reimbursement accounts for the amount of savings received through the card. You can use HSA/FSA for the portion you actually pay out of pocket.
If you use the Self-Pay Savings Card: The terms state you may not seek or accept reimbursement from any third-party payer or healthcare reimbursement account for Foundayo purchased with the card. More restrictive — consult your tax advisor before using HSA/FSA funds.
If you’re paying regular price without any savings card: Standard HSA/FSA rules apply. Foundayo prescribed for an FDA-approved indication qualifies as a deductible medical expense.
What If Your Insurance Says No?
Not all denials are the same. Understanding which type you got determines whether fighting makes sense or switching paths gets you started faster.
| Why you were denied | Is it fixable? | Best next step |
|---|---|---|
| Missing documentation — PA wasn't submitted or was incomplete | Usually yes | Have your provider resubmit with BMI, comorbidity documentation, and weight-management history |
| Foundayo not on formulary — plan covers other GLP-1s but not this one | Sometimes | Request a formulary exception; argue medical necessity based on oral dosing, needle aversion, or treatment failure with alternatives |
| Step therapy required — plan wants you to try another GLP-1 first | Often fixable with time | Discuss with your provider whether completing step therapy or requesting an exception is the better path |
| Plan excludes weight-loss drugs entirely | Rarely fixable by appeal | Benefit design exclusion — appeals have low success rates. Self-pay ($149/mo starting dose) or switching plans at open enrollment is more realistic. |
The appeal numbers that should change your thinking
According to KFF analysis of CMS data, in 2024, only 11.5% of denied Medicare Advantage prior authorization requests were appealed — yet in each year from 2019 through 2024, more than 8 in 10 appealed denials were partially or fully overturned. The pattern for commercial plans is similar: most denials that get challenged get reversed, but most patients give up without trying.
If You Decide to Appeal
- 1.Get the denial in writing. Request the specific reason and your plan's appeal deadlines (most plans give 180 days under ACA rules).
- 2.Partner with your doctor's office. Ask for whoever handles PA appeals. Your provider can request a peer-to-peer review — a direct phone call between your doctor and the insurer's medical reviewer. This is often where approvals happen.
- 3.File the formal written appeal with: the PA reference number, your diagnosis, BMI documentation, weight-related comorbidities, evidence of lifestyle modification, and a letter of medical necessity.
- 4.Know your escalation options: internal appeal → external review by an independent third party. For self-funded employer plans, you can also appeal directly to HR.
You can also start self-pay immediately while an appeal processes — if the appeal wins later, switch to insurance going forward.
See if your denial is fixable — Ro’s free coverage checker can confirm whether your plan covers Foundayo and what your options are before you appeal.
See If Your Denial Is Fixable — Check Coverage for Free →How to Check Foundayo Coverage the Fastest Way Possible
If You Have Commercial Insurance
Check your formulary. Search your insurer’s website for “prescription drug list” or “formulary search.” Look up orforglipron or Foundayo.
Call the number on the back of your card and ask:
Use a free coverage-checking service. Ro’s GLP-1 Insurance Coverage Checker contacts your insurer directly and returns a report showing coverage, PA requirements, and estimated copay. Free, takes minutes.
If You Have Medicare
Before July 1, 2026: Standard Part D does not cover Foundayo for weight loss. Self-pay at $149–$349/month.
Starting July 1, 2026: Ask your prescriber whether you meet the GLP-1 Bridge eligibility criteria (see the three-tier table above). If you qualify and Foundayo is confirmed for the Bridge, your prescriber submits to the CMS central processor — not your Part D plan.
If You Have Medicaid
Contact your state Medicaid office or managed care plan. Ask whether orforglipron (Foundayo) is on the preferred drug list for weight management. Don’t assume national headlines apply to your state.
Is Ro, LillyDirect, or Your Regular Doctor the Best Path?
They solve different problems.
| Ro | LillyDirect | Your Prescriber | |
|---|---|---|---|
| Free coverage check | Yes (commercial only) | Monitors ongoing coverage | By request |
| Handles PA paperwork | Yes (commercial only) | Yes | Yes |
| Medicare Bridge submission | No | No | Yes — to CMS central processor |
| Foundayo self-pay price | $149/mo + membership | $149/mo (no membership) | Pharmacy pricing varies |
| Other GLP-1 options | Yes (Wegovy, Zepbound, etc.) | Lilly products only | Full formulary access |
| Membership required | $39 first month, then as low as $74/mo annual | No | No (standard visit fees) |
| Government insurance | Medicare/TRICARE can pay cash; Medicaid cannot join Ro Body | N/A — self-pay platform | Accepts Medicare, Medicaid |
Ro works best for people with commercial insurance who want someone else to navigate the coverage maze.
LillyDirect works best for self-pay patients who want the simplest, no-membership path at manufacturer pricing.
Your regular doctor works best for Medicare beneficiaries pursuing the Bridge, complex PA cases requiring peer-to-peer review, and anyone who wants weight management integrated with existing care.
What Most Pages Get Wrong About Foundayo Coverage
The Two Savings Cards Are Not the Same Program
Multiple competing pages conflate the covered-commercial Savings Card with the Self-Pay Savings Card. They have different eligibility rules, different savings caps, and different reimbursement restrictions. The commercial card caps savings at $100/month; the self-pay card caps your total price at $149–$299 by dose.
“Covered” Does Not Mean “Easy”
Even when a commercial plan covers Foundayo, prior authorization and step therapy requirements are common. “Covered” means it’s possible — not friction-free.
Commercial, Medicare, and Medicaid Are Different Systems
Pages that say “insurance may cover Foundayo” without separating these three systems leave Medicare readers expecting the $25 savings card (which they can’t use) and Medicaid readers expecting coverage their state may not offer.
At Least One Competing Page Has the Facts Wrong
We found a result calling Foundayo “investigational” and citing $2,000–$15,000 cost ranges. Foundayo received FDA approval on April 1, 2026. Lilly’s verified self-pay pricing is $149–$349/month. The grid at the top of this page reflects what we verified directly from primary sources.
Real Feedback on the Coverage Navigation Experience
We include positive and critical feedback because realistic expectations matter more than a highlight reel. These are service observations — not evidence of medical outcomes or insurance approval rates.
“I was not expecting insurance help. Usually patients are their own advocate, so I was thrilled to not have to fight for my coverage.”
“The communication has been excellent. Responses are quicker than expected…”
“The stated practice of having a concierge service… felt like a bait and switch.”
What We Actually Verified for This Page
- ✓FDA approval: Foundayo (orforglipron) approved April 1, 2026. Source: FDA, Eli Lilly investor release.
- ✓Covered-commercial Savings Card: As low as $25/mo; savings capped at $100/fill (1-month), $200 (2-month), $300 (3-month); $1,000 annual cap; 10 fills/year; expires 12/31/2026; government beneficiaries excluded. Source: Lilly Foundayo Full Terms & Conditions, verified April 2026.
- ✓Self-Pay Savings Card: $149 (0.8mg), $199 (2.5mg), $299 (5.5–17.2mg); 45-day refill requirement for top-dose pricing; reimbursement restrictions apply. Source: Lilly Foundayo Full Terms & Conditions, verified April 2026.
- ✓Medicare GLP-1 Bridge: $50/mo copay, July 1–Dec. 31, 2026, operates outside Part D, confirmed for Wegovy and Zepbound. Lilly states Foundayo will be included; CMS has not yet confirmed. Sources: CMS GLP-1 Bridge FAQ (March 2026), Lilly press release (April 2026).
- ✓BALANCE Model: Medicaid from May 2026, Medicare Part D from Jan 2027, coverage not guaranteed. Source: CMS.gov.
- ✓Medicaid state count: 13 state FFS programs covering GLP-1s for obesity, Jan 2026, down from 16. Source: KFF.
- ✓Employer coverage: 49% of large employers (500+) covered GLP-1 weight-loss drugs in 2025. Source: Mercer.
- ✓PA appeal success: 11.5% of denied MA PA requests were appealed in 2024; more than 8 in 10 appealed denials were overturned (2019–2024). Source: KFF analysis of CMS data.
- ✓Ro pricing: $39 first month, as low as $74/mo annual. Source: ro.co/weight-loss/pricing, verified April 2026.
How this page was produced: We verified FDA approval status, Lilly pricing and savings terms from the full terms and conditions page, CMS Bridge and BALANCE guidance, Ro coverage-checking policies, and employer coverage data before publishing. No pharmaceutical companies reviewed or approved this content.
Frequently Asked Questions
Does insurance cover Foundayo?
Sometimes. Some commercial plans cover Foundayo with prior authorization, and eligible patients with coverage can use the Foundayo Savings Card to pay as low as $25/month (subject to savings caps). Medicare Part D does not cover Foundayo under standard rules, but the CMS Medicare GLP-1 Bridge may provide access at $50/month starting July 1, 2026. Medicaid coverage varies by state, with 13 state fee-for-service programs covering GLP-1s for obesity as of January 2026.
Does Medicare cover Foundayo?
Not under standard Part D. CMS created a Medicare GLP-1 Bridge launching July 1, 2026 for eligible beneficiaries at $50/month. Lilly has stated Foundayo will be included, though CMS has not yet confirmed this post-approval. The Bridge requires specific BMI and comorbidity criteria and runs through December 31, 2026.
Does Medicaid cover Foundayo?
In some states. KFF identified 13 state Medicaid fee-for-service programs covering GLP-1s for obesity as of January 2026, down from 16 in late 2025. The CMS BALANCE Model may expand coverage starting May 2026, but it does not guarantee coverage for any individual.
How much does Foundayo cost with insurance?
With commercial insurance that covers Foundayo plus the Savings Card, eligible patients may pay as low as $25/month, subject to a $100/month savings cap and $1,000 annual cap. Through the Medicare GLP-1 Bridge (if Foundayo is included), the copay is $50/month.
Can I use the Foundayo Savings Card with Medicare or Medicaid?
The commercial Foundayo Savings Card excludes government insurance beneficiaries. The Medicare GLP-1 Bridge does not allow manufacturer copay cards on Bridge claims. The Self-Pay Savings Card has separate terms for cash-paying patients with restrictions on third-party reimbursement.
What if my insurance denies Foundayo?
Determine the denial reason. Missing documentation and non-formulary denials are often fixable. KFF data shows more than 8 in 10 appealed Medicare Advantage PA denials are overturned, yet only 11.5% of patients appeal. If your plan categorically excludes weight-loss drugs, self-pay at $149/month or switching plans may be more practical.
Do you need prior authorization for Foundayo?
Authorization requirements are common for GLP-1 medications prescribed for weight management under commercial insurance. Self-pay patients do not need prior authorization, only a prescription.
What happens after the Medicare GLP-1 Bridge ends in December 2026?
Continued Medicare coverage depends on the BALANCE Model launching in January 2027. Beneficiaries would need to enroll in a participating Part D plan, which may require switching plans during fall 2026 open enrollment.
Is there a generic or compounded version of Foundayo?
No generic exists. Foundayo (orforglipron) is available only as a brand-name product from Eli Lilly. The FDA has expressed concerns about unapproved compounded GLP-1 products, including safety, potency, and sterility risks.
Still not sure which GLP-1 program is right for you?
Our free 60-second quiz considers your diagnosis, insurance, budget, and preferences to match you to the right path. No sign-up required.
Take Our Free GLP-1 Matching Quiz →Related guides
Affiliate disclosure: The RX Index may earn a commission when you use provider links on this page. This does not affect the accuracy of the information presented or our editorial independence.
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Foundayo is a trademark of Eli Lilly and Company. Consult a licensed healthcare provider about your specific health situation. All pricing and coverage information is subject to change without notice.
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We re-verify pricing and coverage information monthly.